NUCLEATE BIO INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,046,905
Cash & Equivalents
78%
Receivables (Non-Related)
22%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$319,083
Deferred Revenue
97%
Payables & Accruals
3%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$653,970
$819,941
+25%
Receivables (Non-Related)
$89,680
$226,964
+153%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
-
-
-
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$743,650
$1,046,905
+41%
Liabilities
2023
2024
Change
Payables & Accruals
$42,912
$8,975
-79%
Grants Payable
-
-
-
Deferred Revenue
$186,431
$310,108
+66%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$229,343
$319,083
+39%
Net assets
2023
2024
Change
Restricted Net Assets
$218,063
$301,484
+38%
Unrestricted Net Assets
$296,244
$426,338
+44%
Net assets
2023
2024
Change
Net assets
+$514,307
+$727,822
+42%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)